Chemical Compound
Telavancin Hydrochloride
CAS Registry Number
560130-42-9
Primary Record
Telavancin Hydrochloride
- In stock
- 1,727 g
- Purity
- 98.8 %
- CAS
- 560130-42-9
Compound Identifiers & Properties
- CAS
- 560130-42-9
- PubChem CID
- 9812715
- SMILES
- CCCCCCCCCCNCCN[C@]1(C[C@@H](O[C@H]([C@H]1O)C)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C(=C(C=C9[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)CNCP(=O)(O)O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)C.Cl
- Canonical SMILES
- CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O.Cl
Names & Synonyms
- Telavancin Hydrochloride
- Telavancin HCl
- Vibativ
- Telavancin
- Arbelic
- Televancin hydrochloride
- Vibativ (TN)
- 560130-42-9
- Telavancin (hydrochloride)
- RefChem:56920
- Telavancin hydrochloride [USAN]
- D02IJB
- TD-6424
- Td 6424
- CHEBI:71226
- UNII-0701472ZG0
- CHEMBL3301680
- SCHEMBL29355205
- Telavancin hydrochloride (USAN)
- SIB-1533A
- C80H107Cl3N11O27P
- TELAVANCIN MONOHYDROCHLORIDE
- EX-A7014
- MFCD22572780
- TELAVANCIN HYDROCHLORIDE [MI]
- 0701472ZG0
- Telavancin Hydrochloride [USAN:INN]
- AT76368
- CID9812715
- EBC-153172
- TELAVANCIN HYDROCHLORIDE [MART.]
- TELAVANCIN HYDROCHLORIDE [VANDF]
- TELEVANCIN HYDROCHLORIDE [VANDF]
- TELAVANCIN HYDROCHLORIDE [WHO-DD]
- HY-16485
- CS-0006359
- TELAVANCIN HYDROCHLORIDE [ORANGE BOOK]
- D06057
- (1S,2R,18R,19R,22S,25R,28R,40S)-22-(2-amino-2-oxoethyl)-5,15-dichloro-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-[2-(decylamino)ethylamino]-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,18,32,35,37-pentahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-36-[(phosphonomethylamino)methyl]-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid;hydrochloride
- Q47495786
- B0046-464010
- 380636-75-9
- VANCOMYCIN, N(SUP 3'')-(2-(DECYLAMINO)ETHYL)-29-(((PHOSPHONOMETHYL)AMINO)METHYL)-, MONOHYDROCHLORIDE
- Vancomycin, N3''-(2-(decylamino)ethyl)-29-(((phosphonomethyl)amino)methyl)-, hydrochloride (1:1)
- (1S,2R,18R,19R,22S,25R,28R,40S)-22-(2-amino-2-oxo-ethyl)-5,15-dichloro-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-[2-(decylamino)ethylamino]-5-hydroxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2,18,32,35,37-pentahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-36-[(phosphonomethylamino)methyl]-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid;hydrochloride
- (3S,6R,7R,22R,23S,26S,36R,38aR)-3-(2-Amino-2-oxoethyl)-10,19-dichloro-44-((2-O-(3-((2-(decylamino)ethyl)amino)-3-C-methyl-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl)oxy)-7,22,28,30,32-pentahydroxy-6-(((2R)-4-methyl-2-(methylamino)pentanoyl)amino)-2,5,24,38,39-pentaoxo-29-(((phosphonomethyl)amino)methyl)-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-8,11:18,21-dietheno-23,36-(iminomethano)-22H-13,16:31,35-dimetheno-1H,13H-(1,6,9)oxadiazacyclohexadecino(4,5-m)(10,2,16)benzoxadiazacyclotetracosine-26-carboxylic acid monohydrochloride
- 372151-71-8
- N3 inverted exclamation marka inverted exclamation marka-[2-(Decylamino)ethyl]-29-[[(phosphonomethyl)amino]methyl]vancomycin hydrochloride
- TLV
- Vancomycin, N3'-(2-(decylamino)ethyl)-29-(((phosphonomethyl)amino)methyl)-, monohydrochloride